Quent Capital, LLC Alkermes Plc. Transaction History
Quent Capital, LLC
- $950 Million
- Q3 2024
A detailed history of Quent Capital, LLC transactions in Alkermes Plc. stock. As of the latest transaction made, Quent Capital, LLC holds 552 shares of ALKS stock, worth $16,399. This represents 0.0% of its overall portfolio holdings.
Number of Shares
552
Previous 552
-0.0%
Holding current value
$16,399
Previous $13,000
15.38%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding ALKS
# of Institutions
362Shares Held
181MCall Options Held
175KPut Options Held
96.6K-
Black Rock Inc. New York, NY29.1MShares$865 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA19MShares$564 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD13MShares$386 Million0.04% of portfolio
-
Wellington Management Group LLP Boston, MA12.7MShares$376 Million0.06% of portfolio
-
State Street Corp Boston, MA9.19MShares$273 Million0.01% of portfolio
About Alkermes plc.
- Ticker ALKS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 164,254,000
- Market Cap $4.88B
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...